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DISPARATE EFFICACY OF COLLAGEN HYDROLYSATE
AND GLUCOSAMINE ON THE EXTRACELLULAR MATRIX
METABOLISM OF ARTICULAR CHONDROCYTES
M. Schunck1, C.H. Schulze2, S. Oesser1
1Collagen Research Institute, Kiel, Germany, 2Department of
General Surgery and Traumatology, Klinikum Elmshorn,
Elmshorn, Germany
Purpose: Glucosamine has been used in the treatment of os-
teoarthritis (OA) for several years. More recently, collagen frag-
ments were shown to provide a positive effect on joint health.
The objective of this study was to investigate the efficacy of a
specific type of collagen hydrolysate (CH) on the biosynthesis
of ECM macromolecules in comparison with glucosamine sul-
fate (GS) and glucosamine hydrochloride (GH) in a chondrocyte
culture model.
Methods: Primary porcine articular chondrocytes and human
femoral head chondrocytes were cultured under reduced oxygen
conditions. The culture medium was supplemented with various
concentrations of CH. In parallel experiments chondrocytes were
treated with either GS or GH in various concentrations up to
2.5mM. At the end of the culture period the amount of cell-
associated proteoglycans (PGs) and the extent of PG synthesis
were quantified by measuring 35S-sulfate incorporation and by
colorimetric assay. The amount of aggrecan accumulated in the
ECM was determined by Western Blotting. In addition, type II col-
lagen biosynthesis was quantified by means of ELISA technique.
The results were confirmed by immunocytochemical detection of
type II collagen and by analyzing the incorporation of 14C-proline
into matrix proteins.
Results: Supplementation of the culture medium with CH re-
sulted in a statistically significant (p<0.05) increase of PG syn-
thesis. The amount of cell-associated PGs was almost doubled
after CH treatment, compared with the control cells. Adminis-
tration of CH was also associated with increased aggrecan ex-
pression and a statistically significant (p<0.05) 1.5-fold increase
of type II collagen biosynthesis. In contrast, the administration
of GS or GH had no stimulatory effect on the type II colla-
gen biosynthesis of the chondrocytes. Moreover, although slight
differences could be observed between GS and GH, supplemen-
tation of glucosamine had no significant effect on the amount
of cell-associated PGs, or total PG synthesis, compared to the
controls.
Conclusions: These results indicate a stimulatory effect of CH
on the synthesis of PG and type II collagen. In contrast, GS and
GH failed to stimulate the synthesis extracellular matrix (ECM)
macromolecules by chondrocytes.
These data suggest that CH may help reduce degenerative
changes of the ECM by stimulating anabolic processes in carti-
lage tissue.
P200
TGF-β1 PROTECTS OA, BUT NOT NORMAL, HUMAN
CHONDROCYTES FROM Ro 31-8220 AND TNF-α
INDUCED APOPTOSIS
M. Lires-Deán, M.J. López-Armada, B. Caramés,
B. Cillero-Pastor, B. Lema, F.J. Blanco
Osteoarticular and Aging Research Laboratory. Biomedical
Research Center, CHU Juan Canalejo, A Coruña, Spain
Purpose: Death of chondrocyte cells by apoptosis is a hallmark
of degenerative joint diseases such as osteoarthritis (OA). Com-
bination of Tumour Necrosis Factor α (TNF-α) and Ro 31-8220
(Ro) have been proved to induce apoptosis in chondrocytes.
Transforming Growth Factor β-1 (TGF-β1) is a pleiotropic cito-
quine that provides signals for both cell survival and apoptosis,
the final output depending on cell type and cellular context.
Objectives: In this work, we studied if TGF-β1 is able to protect
human chondrocytes from apoptosis induced by an in vitro model
(TNF-α + Ro), both in OA and normal chondrocytes.
Methods: Human OA and N cartilage was obtained from the
femoral heads of 8 patients each. OA cartilage was obtained from
patients who were undergoing joint replacement while normal
cartilage was obtained from cadavers who had no history of
joint disease and who had macroscopically normal cartilage.
Apoptosis was asessed by flow cytometry (propidium iodide)
and ELISA cell death, while nuclear morphology was evaluated
using the fluorescent stain DAPI (4’,6-diamidino-2-phenylindole,
dihydrochloride).
Results: It was established two groups of cells, one group was
preincubated for 120h with TGF-β1, while the another group was
not, both in OA cells and normal cells. Afterwards, both groups
were stimulated with TNF- α and Ro for 16h. In OA cells, TGF-β1
significantly reduced the percentage of hypodiploid chondrocytes
(TNF-α+Ro 18.6% vs TGF-β1+ TNF-α+Ro 8.9%, p< 0.05), just
as the percentage of internucleosomal DNA breakage (TGF-β1+
TNF-α+Ro 40.3% vs TNF-α+Ro 100%; p< 0.05), as a result of
apoptotic induction. However, in normal chondrocytes, TGF-β1
did not induce protection against apoptosis as we asses both
the percentage of hypodiploid chondrocytes (TNF-α+Ro 20.3%
vs TGF-β1+ TNF-α+Ro 25.2%, p= 0.381) and internucleosomal
DNA breakage (TGF-β1+ TNF-α+Ro 83.0% vs TNF-α+Ro 100%
p= 0.391). Furthermore, nuclear morphology using DAPI fits well
with previous results, both in OA and normal chondrocytes.
Conclusions: These results show that TGF-β1 is able to par-
tially blocks the apoptosis induced by TNF-α+Ro 31-8220 in OA
chondrocytes, but not in normal chondrocytes. In some way,
this result emulate the pleiotropic behaviour of TGF-β1 in vivo,
providing a model to study the differences at signal transduction
triggered by TGF- β1 in OA and normal chondrocytes.
P201
DERMATAN SULFATE REMOVAL DOES NOT CHANGE
INDENTATION PROPERTIES OF ARTICULAR CARTILAGE
J. Lewis, M. Hall, D. Krawczak, N. Simha
University of Minnesota, Minneapolis, MN
Purpose: Decorin is attached to the Type II collagen fibrils in
articular cartilage. It has been hypothesized that the dermatan
sulfate (DS) attached to the decorin core protein projects out from
the protein and forms a bond with adjacent fibrils, either directly
to another DS chain or through an intermediary molecule, thus
serving as a gluing molecule between the collagen molecules.
As such, decorin would serve as a structural molecule, carry
load in cartilage, and its damage would lead to change in me-
chanical properties. The purpose of this study was to to test
this hypothesis by digesting DS in bovine patellar cartilage with
chondroitinase B (cB) and testing the cartilage by indentation
before and after digestion.
Methods: Articular cartilage from bovine patella was tested in
indentation before and after digesting with cB. For comparison,
to validate our methods, we also tested cartilage before and
after digestion with chondroitinase ACI (cAC), an agent known
to alter indentation properties. In both cases, controls were
cartilage specimens treated in the same way in buffer, without
the enzyme. Digestion was with 0.1U/ml for 24 hrs at 37 0F with
gentle agitation. Indentation was with a 2 mm diameter flat ended
non-porous cylinder on an ELF 3100 (Bose, Inc., Minneapolis,
MN). Indentation was with a series of 7 step-hold displacements.
Step loads were applied in approximately 0.1 sec; hold times
were 300 sec. Instantaneous modulus, equilibrium modulus, and
relaxation function were determined for each test. 5 indents for
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each condition were performed on 4 test/control pairs for both
cB and cAC.
To verify that the cB removed a significant amount of the DS,
specimens were cut into 14 sections, 7 in a top half layer and
7 in a bottom half layer, and Western blot analysis for the
decorin protein performed on each section. For comparison, cAC
specimens were cut in a similar fashion and total proteoglycans
assayed with the DMB assay.
Results: cB had no detectable effect on rapid modulus, equilib-
rium modulus, or relaxation function in indentation. Conversely,
cAC caused reduction in equilibrium modulus and relaxation
function, consistent with published work of others. Approximately
one-half of the DS was removed from the top layer. Assay of the
cAC specimens for total proteoglycan showed similar digestion
patterns, suggesting that the two enzymes acted similarly.
Conclusions: Removal of DS from the cartilage did not affect
the viscoelastic properties of the cartilage, indicating that decorin
is not a structural molecule in cartilage in indentation.
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ACTIVATION OF C-JUN N-TERMINAL KINASE (JNK) IN
ARTICULAR CHONDROCYTES BY MERCURY AND LEAD
J.B. Collins, J.W. Neal, R.D. Graff
UNC School of Medicine, Chapel Hill, NC
Purpose: There is growing recognition that environmental fac-
tors may play a significant role in determining the health of
musculoskeletal tissues, including cartilage. Many of the cellu-
lar mechanisms that contribute to cartilage catabolism such as
oxidative stress, altered growth factor signaling, matrix mineral-
ization and activation of metaloproteinases can be initiated by
heavy metal toxicants. The aim of this study was to determine
if heavy metal toxicants activate chondrocyte mitogen-activated
protein kinases (MAPKs) that can then lead to altered cartilage
homeostasis.
Methods: Chondrocytes were enzymatically isolated from com-
mercially obtained 4-6 month-old porcine knee joints (approved
by the UNC IACUC) by sequential digestion in pronase and
collagenase, and grown in high-density monolayer culture (105
cells/cm2). Cultures were serum-starved overnight and subse-
quently treated with organic methylmercury (MeHg), inorganic
mercuric chloride (HgCl2), or lead acetate (PbAc), for up to 60
minutes at varying concentrations prior to cell extraction with
ice-cold lysis buffer. Additional cultured were treated with IL-1.
Activation of MAPKs was determined by western blotting using
phosphorylation-specific polyclonal antibodies.
Results: MeHg and caused transient activation of JNK at con-
centrations as low as 1uM, though the degree of activation by
MeHg was lower than by IL-1. Maximal activation occured at
10 minutes, returning to baseline levels within 30 minutes. p38
MAPK was activated by IL-1, but not MeHg or HgCl2, within this
time frame. HgCl2 and PbAc treatments also caused transient
activation of JNK, with maximal activation at 10 minutes.
Conclusions: Environmental toxicants are recognized as con-
tributing factors in many chronic human diseases. This study
demonstrates that environmental heavy metals activate JNK in
articular chondrocytes and suggests that metals may influence
the rate or severity of osteoarthritis through modulation of intra-
cellular signaling pathways.
P203
INHIBITION OF IL-1β-INDUCED HUMAN CARTILAGE
DEGRADATION BY POMEGRANATE
M. Shukla1, K. Gupta1, K.A. Khan2, C.J. Malemud1,
T.M. Haqqi1
1Case Western Reserve University, Cleveland, OH, 2Aligarh
Muslim University, Aligarh, India
Purpose: Pomegranate fruit (Punica granatum L) is revered
through the ages for its medicinal properties. Pomegranate fruit
(PF) or its extract (PFE) is widely used in Asian and Mediter-
ranean cultures for the treatment of inflammation, for pain in
arthritis and other diseases. Osteoarthritis (OA) is the most
common musculoskeletal disease among the aging population.
Pro-inflammatory cytokine IL-1β plays a dominant role in OA
pathogenesis which is characterized by degeneration of articular
cartilage of the joints in hands, knees, spine and hips. We have
evaluated the effects of a standardized PFE preparation on hu-
man OA cartilage and OA chondrocytes treated with IL-1β with a
view to determining whether consumption of PF or PFE can be
useful in preventing joint cartilage degradation in OA.
Methods: Human cartilage and synovial fluid (SF) were obtained
at the time of hip arthroplasty. Cartilage explants were prepared
by standard methods and chondrocytes were liberated by en-
zymatic dissociation from femoral heads. Cartilage explants or
chondrocytes were treated with IL-1β (5 ng/ml) or IL-1β and
PFE (10 - 200 μg/ml) using previously described methods. The
effect of PFE on IL-1β-induced apoptosis in chondrocytes was
determined by viability assays and Western blotting. Substrate-
embedded enzymography and/or collagen degradation assays
were used to characterize the MMP activity in conditioned me-
dia and SF. Western immunoblotting and immunoprecipitation
was used to confirm the presence and/or interaction of specific
proteins in the SF and conditioned media. Quantitative RT-PCR
was employed to quantify MMP mRNA expression levels. Human
chondrocyte nucleofection with reporter constructs was used to
analyze the effect of PFE on IL-1β-induced gene promoter activ-
ity. Cartilage explants were stained with Safranin-O/Fast Green.
Matrix proteoglycan and collagen degradation was determined
in culture supernatant using metachromatic assays. The results
were analyzed using the Student-t test where p<0.05 was con-
sidered significant.
Results: PFE at the concentrations used was found to be non-
toxic and remarkably effective in inhibiting IL-1β-induced human
chondrocyte apoptosis. PFE also blocked the gelatinolytic ac-
tivities of recombinant human MMPs as well as MMP activity
recovered from SF of OA patients. Quantitative zymography
also showed that in IL-1β-stimulated human chondrocytes cul-
tures pretreated with PFE the substrate degrading activity of
MMP-9 and MMP-13 was significantly lower (p <0.05). Western
immunoblotting showed that IL-1β-induced protein expression
of MMP-9 and MMP-13 was inhibited when human chondro-
cytes were pre-treated with PFE. Quantitative RT-PCR showed
that PFE blocked MMP-9 and MMP-13 mRNA expression. Fur-
thermore, PFE inhibited IL-1β-induced MMP-9 and -13 gene
promoter activity (p <0.005) in transfected human chondrocytes
indicating that PFE was acting at the level of transcription.
Histochemical and biochemical analysis of human cartilage ex-
plants showed that the proteoglycan and Type-II collagen content
loss was significantly less (p <0.05) in cartilage explants when
PFE was present during IL-1β stimulation or when activated re-
combinant MMPs were exogenously added to explant cultures
pretreated with PFE. Chondrocytes cultured in the presence of
PFE also showed increased proteoglycan and collagen synthe-
sis. PFE also blocked the IL-1β-induced loss and inhibition of
matrix synthesis.
Conclusions: Our results indicated that PFE blocked the IL-1β-
induced human cartilage degradation and MMP-9 and MMP-13
